ACADIAN ASSET MANAGEMENT LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 139 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$57,000
+32.6%
15,9140.0%0.00%
Q2 2019$43,000
-94.8%
15,914
-94.3%
0.00%
-100.0%
Q1 2019$825,000
+1912.2%
278,573
+973.1%
0.00%
Q4 2018$41,000
-69.6%
25,960
-45.5%
0.00%
-100.0%
Q2 2018$135,000
-55.9%
47,670
-42.2%
0.00%0.0%
Q1 2018$306,00082,4780.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders